These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25667128)

  • 21. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
    Piñana JL; Valcárcel D; Martino R; Barba P; Moreno E; Sureda A; Vega M; Delgado J; Briones J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):21-9. PubMed ID: 19135939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Rovó A; Tichelli A;
    Semin Hematol; 2012 Jan; 49(1):25-34. PubMed ID: 22221782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.
    Norkin M; Hsu JW; Wingard JR
    Semin Hematol; 2012 Jan; 49(1):104-9. PubMed ID: 22221790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis.
    Zhou J; Nutescu EA; Han J; Calip GS
    J Cancer Surviv; 2020 Jun; 14(3):294-304. PubMed ID: 31897877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell transplantation: supportive care and long-term complications.
    Wingard JR; Vogelsang GB; Deeg HJ
    Hematology Am Soc Hematol Educ Program; 2002; ():422-44. PubMed ID: 12446435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning.
    Freycon F; Trombert-Paviot B; Casagranda L; Frappaz D; Mialou V; Armari-Alla C; Gomez F; Faure-Conter C; Plantaz D; Berger C;
    Pediatr Hematol Oncol; 2014 Apr; 31(3):225-36. PubMed ID: 24087985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.
    Morken CM; Tevaarwerk AJ; Swiecichowski AK; Haine JE; Williams ZT; Norslien K; Arroyo N; Zhang X; Campbell B; Mendonca EA; Juckett MB; Sesto ME
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1240-1246. PubMed ID: 30763727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation: a primer for the primary care physician.
    Léger CS; Nevill TJ
    CMAJ; 2004 May; 170(10):1569-77. PubMed ID: 15136552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term complications after hematopoietic cell transplantation.
    Majhail NS
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):220-227. PubMed ID: 28641097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-endocrine late complications in children after allogeneic haematopoietic SCT.
    Faraci M; Békássy AN; De Fazio V; Tichelli A; Dini G;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S49-57. PubMed ID: 18545245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivorship issues in hematopoietic stem cell transplantation.
    Buchsel PC
    Semin Oncol Nurs; 2009 May; 25(2):159-69. PubMed ID: 19411019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.
    Bresters D; van Gils IC; Kollen WJ; Ball LM; Oostdijk W; van der Bom JG; Egeler RM
    Bone Marrow Transplant; 2010 Jan; 45(1):79-85. PubMed ID: 19421172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.
    Bevans MF; Mitchell SA; Barrett AJ; Bishop M; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L
    Health Qual Life Outcomes; 2011 Apr; 9():24. PubMed ID: 21496339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
    Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation.
    Frangoul H; Najjar J; Simmons J; Domm J
    Semin Hematol; 2012 Jan; 49(1):94-103. PubMed ID: 22221789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.